NHL

Oncology

26 drugs in development·20 companies·0 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
belrapzo	EAGLE PHARMACEUTICALS, INC. (EGRX)

Phase 3(3)

Drug	Company
alxn2075	ALEXION PHARMACEUTICALS, INC. (ALXN)
CD19/CD22-CAR-transduced T cells	Filana Therapeutics Inc. (FLNA)
jcar017	Juno Therapeutics, Inc. (JUNO)

Phase 2(6)

Drug	Company
AUCATZYL/obe-cel	Autolus Therapeutics plc (AUTL)
azacitadine	AbbVie Inc. (ABBV)
bbt369	2seventy bio, Inc. (TSVT)
cnct19	CASI Pharmaceuticals, Inc (DE) (CASI)
Mivavotinib (CB-659, formerly TAK-659)	Calithera Biosciences, Inc. (CALA)
tak-007	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)

Phase 1(10)

Drug	Company
ARV-393	ARVINAS, INC. (ARVN)
jcar014	Juno Therapeutics, Inc. (JUNO)
KRAS TCR-Transduced PBL	Filana Therapeutics Inc. (FLNA)
mb-106	MUSTANG BIO, INC. (MBIO)
odronextamab	REGENERON PHARMACEUTICALS, INC. (REGN)
pit565	Novartis AG (NVS)
pit565	Novartis AG (NVS)
prt2527	Prelude Therapeutics Inc (PRLD)
regn5837	REGENERON PHARMACEUTICALS, INC. (REGN)
vispa-cel	Caribou Biosciences, Inc. (CRBU)

Preclinical(1)

Drug	Company
duet-03	Scopus BioPharma Inc. (SCPS)

Phase 1/Phase 2(5)

Drug	Company
chemotherapy agents	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
CLLS52	Cellectis S.A. (CLLS)
eb103	ESTRELLA IMMUNOPHARMA, INC. (UPTD)
eb103	Estrella Immunopharma Inc. (ESLA)
UCART20x22	Cellectis S.A. (CLLS)

Compare drugs

belrapzo vs alxn2075 belrapzo vs CD19/CD22-CAR-transduced T cells belrapzo vs jcar017

Deep-dive into NHL

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis